The San Diego company that treats addiction the way it should be treated - fast, affordable, and over the phone.
Somewhere in California right now, a person decides they are done. Done with the drinking, or the pills, or whatever it is that has been quietly rearranging their life. In the old story, this is the moment things fall apart: they call a rehab facility, get quoted a number with too many zeros, land on a waitlist measured in weeks, and by the time an opening appears the resolve has evaporated. The waitlist, it turns out, is where recovery goes to die.
Recover was built to interrupt that story. Reach out today and you can be enrolled today - no waitlist, same-day, in Spanish or English, from your couch. The treatment is not a motivational poster and a group circle. It is medication paired with counseling, the boring evidence-based combination that the data has favored for years, delivered over telehealth and billed to Medi-Cal rather than your credit card.
The company reports that this approach improves outcomes for more than 70% of its patients, and that it costs roughly a tenth of a traditional residential facility. Those are the company's own figures, and addiction outcomes are famously hard to pin down - but the direction is the point. Cheaper. Faster. Reachable. In a field that has spent decades making treatment scarce and expensive, Recover's quiet radicalism is to make it ordinary.
Companies that last are rarely started by people chasing a market. They are started by people who cannot put a problem down. Recover's founder, Nick Gulino, is a Yale Law School graduate who could have done nearly anything with that degree. He chose addiction because he grew up inside it - raised, by his own account, by a drug addict, with an alcoholic brother and an uncle lost to heroin.
He assembled a founding team out of McKinsey - people who could have kept advising from behind a deck of slides, and instead built an actual clinic that enrolls actual patients. That is a meaningful trade. The world has no shortage of reports about the opioid crisis. It has a shortage of people willing to run the thing the reports recommend.
More than 20 million Americans struggle with substance use. Fewer than 10% ever receive treatment. That gap is not about willpower - it is about access, cost, and a system that makes help hard to reach at the exact moment someone reaches for it.
By Recover's count, 48 states cannot meet demand for medication-assisted treatment. When the supply of care is that broken, the fix isn't another expensive building. It's a model that scales - a phone, a prescription, a counselor, and a payer.
For a patient, Recover collapses a maze into a phone call. For a county staring down an overdose crisis with a budget and no scalable option, it is a partner that turns public dollars into same-day care. Here is what the company actually offers.
Evidence-based medication, prescribed and monitored by licensed clinicians, at the center of care.
Start the same day from home - no waitlist, with a Spanish-language option built in.
Behavioral counseling paired with medication to hold recovery together over the long run.
Wraparound support that keeps patients connected to services and engaged in treatment.
Certified by California DHCS and enrolled with Medi-Cal, so cost stops being the barrier.
Contracts with state and local agencies to fund and scale community treatment programs.
Yale Law graduate. Built Recover out of personal experience with addiction and a conviction that treatment should be reachable.
Co-founded Recover and helped shape its early model; now listed as founder emeritus and advisor.
Runs the operational machinery that makes same-day enrollment and telehealth care actually work.
Coordinates the state and county relationships that fund community-based treatment.
Leads clinical care and the evidence-based protocols behind Recover's treatment.
Recover joins Y Combinator's W21 batch, founded by Nick Gulino and a former McKinsey team.
Raises a $130K seed round and begins building its telehealth treatment model.
Becomes certified by California DHCS and in-network with Medi-Cal, unlocking low- and no-cost access for patients.
Reports ~$3.3M annual revenue with a ~22-person team, grown largely on services and public partnerships rather than VC.
Return to that person who decided they were done. In the old story, the waitlist wins. In Recover's version, they are enrolled the same afternoon, prescribed a treatment the evidence supports, matched with a counselor, and never asked to hand over a fortune to begin. The building never mattered. The wait never should have.
Recover has not solved American addiction - no one has, and the honest numbers here are the company's own. But it has done something quietly stubborn: it took the gap between "I need help" and "here's your appointment" and closed it to roughly a day. For 20 million people on the wrong side of that gap, a day is the difference between a story that falls apart and one that holds.
Sources: letsrecover.com, Y Combinator, Crunchbase, PitchBook, Latka, The Org, LinkedIn. Figures such as outcome, cost, and revenue percentages are as reported by the company or third-party databases and are approximate; addiction treatment outcomes vary by individual. Nothing here is medical advice.